Doctors in China found the contacts while performing a procedure to treat a woman's facial asymmetry. The woman assumed she had just lost the lenses.

Marci English, head of biopharma and ophthalmology development at Astellas Pharma, said the FDA's change of heart will ...

So, the supplements are particularly useful for individuals whose atrophy does not yet fully involve ... and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda ...

Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.